News

ADI CEO, Paola Barbarino took to the stage at the ADI 2024 Conference in Krákow, Poland, to highlight the global and national policy landscape on dementia, providing her perspective on the achievements of ADI in the past four decades and hopes for the future.

This year, 2024 marks the 40th year of Alzheimer's Disease International and our work to secure a future that includes greater awareness of the condition, increased access to care, post-diagnostic support,and emerging treatments as well as a achieving a world without stigma. ADI invites our global community to celebrate with us on this momentous occasion with thanks to all who have been with us on this journey over four decades.

The EMA regulates the availability of medicines across all 27 European Union Member States as well as Iceland, Norway, and Liechtenstein.

As we count down the remaining days until the launch of this global event in Kraków, Poland, ADI is proud to share a message from our CEO, Paola Barbarino, and highlight some of our key speakers joining us from 24-26 April 2024.

From symposiums and conferences to high-level meetings and webinars, ADI delegates around the world have taken part in dynamic global efforts to improve the lives of those living with dementia and carers throughout the month of March.

The Wicking Dementia Centre celebrates its achievement of gaining ADI Accreditation, becoming Australia's first educational provider to attain this award. This is a significant milestone in global dementia education and marks Wicking's dedication to excellence and its commitment to enhancing care standards worldwide. 

ADI is pleased to welcome both Her Majesty The Queen Sofía of Spain and Her Royal Highness Princess Muna Al Hussein of Jordan to ADI’s 36th International Conference

ADI’s Director of the Americas attends the ReD-Lat Annual Meeting in Buenos Aires, Argentina with the aim to strengthen the bonds between ADI's members and researchers attending ReD-Lat; fostering collaboration and knowledge exchange to advance the field of dementia research in Latin America and the Caribbean.